Sarepta closes on $600M revolving credit facility

Signature, contract and deal with hands of business people for partnership, meeting and onboarding recruitment. Paperwork, consulting and application with closeup of employees in office for documents

Kobus Louw

  • Sarepta Therapeutics (NASDAQ:SRPT) has closed on a $600M senior secured revolving credit facility made possible with a bank syndicate.
  • JP Morgan Chase (JPM) served as lead arranger and joint bookrunner.
  • The credit facility “supplements our strong balance sheet and allows for

Leave a Reply

Your email address will not be published. Required fields are marked *